AI Drug Discovery
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
163
NCT05844592
First in Human, Single Ascending Dose Study
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 21, 2022
Completion: Aug 31, 2022
NCT05838833
Ointment to Prevent Scar After Thyroidectomy
Phase: Phase 2
Start: Feb 14, 2023
Completion: Jun 30, 2024
NCT06938204
Single Ascending Dose, Multiple Ascending Dose, Food Effect Study
Start: Apr 1, 2024
Completion: Sep 13, 2024
Loading map...